Cargando…

Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication

BACKGROUND: Saliva is an enriched milieu containing biologically active proteins, including growth factors and cytokines. The endothelial growth factor family of proteins is important for the development of blood and lymphatic vessels in a healthy individual but also can aide tumour growth. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Upile, Tahwinder, Jerjes, Waseem, Kafas, Panagiotis, Hirani, Shash, Singh, Sandeep U, Guyer, Marcel, Bentley, Melissa, Sudhoff, Holger, Hopper, Colin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680834/
https://www.ncbi.nlm.nih.gov/pubmed/19393057
http://dx.doi.org/10.1186/1755-7682-2-12
_version_ 1782166975217139712
author Upile, Tahwinder
Jerjes, Waseem
Kafas, Panagiotis
Hirani, Shash
Singh, Sandeep U
Guyer, Marcel
Bentley, Melissa
Sudhoff, Holger
Hopper, Colin
author_facet Upile, Tahwinder
Jerjes, Waseem
Kafas, Panagiotis
Hirani, Shash
Singh, Sandeep U
Guyer, Marcel
Bentley, Melissa
Sudhoff, Holger
Hopper, Colin
author_sort Upile, Tahwinder
collection PubMed
description BACKGROUND: Saliva is an enriched milieu containing biologically active proteins, including growth factors and cytokines. The endothelial growth factor family of proteins is important for the development of blood and lymphatic vessels in a healthy individual but also can aide tumour growth. The aim of this study is to develop an independent normative database of values of salivary VEGF in a healthy population and to test the hypothesis that values would be raised in the saliva of patients with oral cancer. METHODS: Twenty-one participants (12 males and 9 females) of whom 14 were healthy and 7 had oral squamous cell carcinoma took part in this study. An immunoassay was employed to quantify a range of specific vascular endothelial and lymphatic endothelial growth factors in various body fluid compartments (blood, saliva). This was correlated to tumour factors and patient outcomes. RESULTS: The mean salivary levels and serum VEGF A(165 )levels were significantly correlated in the sample as a whole. Additionally, both saliva and serum VEGF A(165 )levels were significantly correlated with age. There were significant differences in the salivary and serum levels of the control group and the cancer group. CONCLUSION: We present independent normative data on the levels of endothelial growth factor in the saliva of a healthy control population. We also suggest the use of simple non-invasive tests in helping to predict head and neck tumour biology and outcomes.
format Text
id pubmed-2680834
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26808342009-05-13 Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication Upile, Tahwinder Jerjes, Waseem Kafas, Panagiotis Hirani, Shash Singh, Sandeep U Guyer, Marcel Bentley, Melissa Sudhoff, Holger Hopper, Colin Int Arch Med Original Research BACKGROUND: Saliva is an enriched milieu containing biologically active proteins, including growth factors and cytokines. The endothelial growth factor family of proteins is important for the development of blood and lymphatic vessels in a healthy individual but also can aide tumour growth. The aim of this study is to develop an independent normative database of values of salivary VEGF in a healthy population and to test the hypothesis that values would be raised in the saliva of patients with oral cancer. METHODS: Twenty-one participants (12 males and 9 females) of whom 14 were healthy and 7 had oral squamous cell carcinoma took part in this study. An immunoassay was employed to quantify a range of specific vascular endothelial and lymphatic endothelial growth factors in various body fluid compartments (blood, saliva). This was correlated to tumour factors and patient outcomes. RESULTS: The mean salivary levels and serum VEGF A(165 )levels were significantly correlated in the sample as a whole. Additionally, both saliva and serum VEGF A(165 )levels were significantly correlated with age. There were significant differences in the salivary and serum levels of the control group and the cancer group. CONCLUSION: We present independent normative data on the levels of endothelial growth factor in the saliva of a healthy control population. We also suggest the use of simple non-invasive tests in helping to predict head and neck tumour biology and outcomes. BioMed Central 2009-04-24 /pmc/articles/PMC2680834/ /pubmed/19393057 http://dx.doi.org/10.1186/1755-7682-2-12 Text en Copyright ©2009 Upile et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Upile, Tahwinder
Jerjes, Waseem
Kafas, Panagiotis
Hirani, Shash
Singh, Sandeep U
Guyer, Marcel
Bentley, Melissa
Sudhoff, Holger
Hopper, Colin
Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication
title Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication
title_full Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication
title_fullStr Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication
title_full_unstemmed Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication
title_short Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication
title_sort salivary vegf: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680834/
https://www.ncbi.nlm.nih.gov/pubmed/19393057
http://dx.doi.org/10.1186/1755-7682-2-12
work_keys_str_mv AT upiletahwinder salivaryvegfanoninvasiveangiogenicandlymphangiogenicproxyinheadandneckcancerprognostication
AT jerjeswaseem salivaryvegfanoninvasiveangiogenicandlymphangiogenicproxyinheadandneckcancerprognostication
AT kafaspanagiotis salivaryvegfanoninvasiveangiogenicandlymphangiogenicproxyinheadandneckcancerprognostication
AT hiranishash salivaryvegfanoninvasiveangiogenicandlymphangiogenicproxyinheadandneckcancerprognostication
AT singhsandeepu salivaryvegfanoninvasiveangiogenicandlymphangiogenicproxyinheadandneckcancerprognostication
AT guyermarcel salivaryvegfanoninvasiveangiogenicandlymphangiogenicproxyinheadandneckcancerprognostication
AT bentleymelissa salivaryvegfanoninvasiveangiogenicandlymphangiogenicproxyinheadandneckcancerprognostication
AT sudhoffholger salivaryvegfanoninvasiveangiogenicandlymphangiogenicproxyinheadandneckcancerprognostication
AT hoppercolin salivaryvegfanoninvasiveangiogenicandlymphangiogenicproxyinheadandneckcancerprognostication